Analysis of Gene Polymorphism CYP2C19 in the Lebanese Population Who Reside in Colombia

Background: The aim of this study is to determine the polymorphism of the CYP2C19 gene in the Lebanese population living in Colombia due to the lack of information and the importance of establishing its behavior which can predict a diminished or increased metabolism of medication related to it. Meth...

Full description

Autores:
Ahmad, Mostapha
Navarro-Quiroz, Elkin
García Moreno, Angélica Margarita
Rios Anillo, Margarita Rosa
Silvera Redondo, Carlos Arturo
Fernandez Ponce, Cecilia
Tipo de recurso:
Fecha de publicación:
2018
Institución:
Universidad Simón Bolívar
Repositorio:
Repositorio Digital USB
Idioma:
eng
OAI Identifier:
oai:bonga.unisimon.edu.co:20.500.12442/2122
Acceso en línea:
http://hdl.handle.net/20.500.12442/2122
Palabra clave:
CYP2C19
Polymorphism
Lebanese
Pharmacogenetics
Rights
License
Licencia de Creative Commons Reconocimiento-NoComercial-CompartirIgual 4.0 Internacional
id USIMONBOL2_1dea625ffc4df4f86b994fd947d6fe7e
oai_identifier_str oai:bonga.unisimon.edu.co:20.500.12442/2122
network_acronym_str USIMONBOL2
network_name_str Repositorio Digital USB
repository_id_str
dc.title.eng.fl_str_mv Analysis of Gene Polymorphism CYP2C19 in the Lebanese Population Who Reside in Colombia
title Analysis of Gene Polymorphism CYP2C19 in the Lebanese Population Who Reside in Colombia
spellingShingle Analysis of Gene Polymorphism CYP2C19 in the Lebanese Population Who Reside in Colombia
CYP2C19
Polymorphism
Lebanese
Pharmacogenetics
title_short Analysis of Gene Polymorphism CYP2C19 in the Lebanese Population Who Reside in Colombia
title_full Analysis of Gene Polymorphism CYP2C19 in the Lebanese Population Who Reside in Colombia
title_fullStr Analysis of Gene Polymorphism CYP2C19 in the Lebanese Population Who Reside in Colombia
title_full_unstemmed Analysis of Gene Polymorphism CYP2C19 in the Lebanese Population Who Reside in Colombia
title_sort Analysis of Gene Polymorphism CYP2C19 in the Lebanese Population Who Reside in Colombia
dc.creator.fl_str_mv Ahmad, Mostapha
Navarro-Quiroz, Elkin
García Moreno, Angélica Margarita
Rios Anillo, Margarita Rosa
Silvera Redondo, Carlos Arturo
Fernandez Ponce, Cecilia
dc.contributor.author.none.fl_str_mv Ahmad, Mostapha
Navarro-Quiroz, Elkin
García Moreno, Angélica Margarita
Rios Anillo, Margarita Rosa
Silvera Redondo, Carlos Arturo
Fernandez Ponce, Cecilia
dc.subject.eng.fl_str_mv CYP2C19
Polymorphism
Lebanese
Pharmacogenetics
topic CYP2C19
Polymorphism
Lebanese
Pharmacogenetics
description Background: The aim of this study is to determine the polymorphism of the CYP2C19 gene in the Lebanese population living in Colombia due to the lack of information and the importance of establishing its behavior which can predict a diminished or increased metabolism of medication related to it. Methods and Results: 109 Lebanese volunteers residents of Colombia were included, genotypes for the CYP2C19 were detected by polymerase Chain Reaction-PCR finding that the most frequent allele was *1 (73.4%), followed by *2 (26.6%) the allele *3 was not found in the studied population. Only fast metabolites were found because of the *1/*1 (73.4%) and *1/*2 (26.6%) genotypes, any *1/*3, *2/*2 or *3/*3 genotype were found. Conclusions: The results obtained show a similar behavior with the alleles frequencies of the previous studies made in Colombia, Africa, Europe and other American population. Knowing the genotype of the population is important for the selection and adjustment of the doses of the best medication to give the optimal treatment in medical practice. The pharmacogenetics will reduce the adverse reactions during medical treatment for a better and more accurate clinical approach.
publishDate 2018
dc.date.accessioned.none.fl_str_mv 2018-06-08T19:36:05Z
dc.date.available.none.fl_str_mv 2018-06-08T19:36:05Z
dc.date.issued.none.fl_str_mv 2018-06
dc.type.eng.fl_str_mv article
dc.type.coar.fl_str_mv http://purl.org/coar/resource_type/c_6501
dc.identifier.issn.none.fl_str_mv 19169744
dc.identifier.uri.none.fl_str_mv http://hdl.handle.net/20.500.12442/2122
identifier_str_mv 19169744
url http://hdl.handle.net/20.500.12442/2122
dc.language.iso.eng.fl_str_mv eng
language eng
dc.rights.coar.fl_str_mv http://purl.org/coar/access_right/c_abf2
dc.rights.license.eng.fl_str_mv Licencia de Creative Commons Reconocimiento-NoComercial-CompartirIgual 4.0 Internacional
rights_invalid_str_mv Licencia de Creative Commons Reconocimiento-NoComercial-CompartirIgual 4.0 Internacional
http://purl.org/coar/access_right/c_abf2
dc.publisher.eng.fl_str_mv Canadian Center of Science and Education
dc.source.eng.fl_str_mv Global Journal of Health Science
dc.source.spa.fl_str_mv Vol. 10, No.7 (2018)
institution Universidad Simón Bolívar
dc.source.uri.spa.fl_str_mv http://www.ccsenet.org/journal/index.php/gjhs/article/view/75742/41884
bitstream.url.fl_str_mv https://bonga.unisimon.edu.co/bitstreams/5e14ddac-0346-4504-bcfd-1e99daa2ed42/download
bitstream.checksum.fl_str_mv 3fdc7b41651299350522650338f5754d
bitstream.checksumAlgorithm.fl_str_mv MD5
repository.name.fl_str_mv DSpace UniSimon
repository.mail.fl_str_mv bibliotecas@biteca.com
_version_ 1814076150859694080
spelling Licencia de Creative Commons Reconocimiento-NoComercial-CompartirIgual 4.0 Internacionalhttp://purl.org/coar/access_right/c_abf2Ahmad, Mostaphae2a2bc14-8863-46f5-a6fc-6020fca57918-1Navarro-Quiroz, Elkinb7f1ab18-ac07-40cf-9df1-f25f0c54e259-1García Moreno, Angélica Margaritac6488b9e-6af2-4a59-b13a-ce1c565abf8e-1Rios Anillo, Margarita Rosa87fff714-d939-4304-9a20-cbca172fc80e-1Silvera Redondo, Carlos Arturo9479c010-3ad2-485a-ac79-13bf8374f7eb-1Fernandez Ponce, Cecilia84dcbd1c-f973-44f4-9f41-e8a9057e69c6-12018-06-08T19:36:05Z2018-06-08T19:36:05Z2018-0619169744http://hdl.handle.net/20.500.12442/2122Background: The aim of this study is to determine the polymorphism of the CYP2C19 gene in the Lebanese population living in Colombia due to the lack of information and the importance of establishing its behavior which can predict a diminished or increased metabolism of medication related to it. Methods and Results: 109 Lebanese volunteers residents of Colombia were included, genotypes for the CYP2C19 were detected by polymerase Chain Reaction-PCR finding that the most frequent allele was *1 (73.4%), followed by *2 (26.6%) the allele *3 was not found in the studied population. Only fast metabolites were found because of the *1/*1 (73.4%) and *1/*2 (26.6%) genotypes, any *1/*3, *2/*2 or *3/*3 genotype were found. Conclusions: The results obtained show a similar behavior with the alleles frequencies of the previous studies made in Colombia, Africa, Europe and other American population. Knowing the genotype of the population is important for the selection and adjustment of the doses of the best medication to give the optimal treatment in medical practice. The pharmacogenetics will reduce the adverse reactions during medical treatment for a better and more accurate clinical approach.engCanadian Center of Science and EducationGlobal Journal of Health ScienceVol. 10, No.7 (2018)http://www.ccsenet.org/journal/index.php/gjhs/article/view/75742/41884CYP2C19PolymorphismLebanesePharmacogeneticsAnalysis of Gene Polymorphism CYP2C19 in the Lebanese Population Who Reside in Colombiaarticlehttp://purl.org/coar/resource_type/c_6501Ćernîk, V., & Viceník, J. (2010). On some methodological questions of historical knowledge [K niektorým metodologickým otázkam historického poznania]. Historicky Casopis, 58(2), 193-212. Retrieved from http://www.scopus.com/inward/record.url?eid=2-s2.0-77954951077&partnerID=40&md5=a174555539bbb 2d2c8123bce8283f826Conney, A. H. (1986). Induction of microsomal cytochrome P-450 enzymes: The first Bernard B. Brodie lecture at Pennsylvania State University. Life Sciences, 39(26), 2493-2518. https://doi.org/10.1016/0024-3205(86)90103-7Goldstein, J. A., Ishizaki, T., Chiba, K., De Morais, S. M. F., Bell, D., Krahn, P. M., & Price Evans, D. A. (1997). Frequencies of the defective CYP2C19 alleles responsible for the mephenytoin poor metabolizer phenotype in various Oriental, Caucasian, Saudi Arabian and American black populations. Pharmacogenetics, 7(1), 59-64. https://doi.org/10.1097/00008571-199702000-00008Ingelman-Sundberg, M., Sim, S. C., Gomez, A., & Rodriguez-Antona, C. (2007). Influence of cytochrome P450 polymorphisms on drug therapies: Pharmacogenetic, pharmacoepigenetic and clinical aspects. Pharmacology and Therapeutics. https://doi.org/10.1016/j.pharmthera.2007.09.004Isaza, C., Henao, J., Isaza Martínez, J. H., Sepúlveda Arias, J. C., & Beltrán, L. (2007). Phenotype-genotype analysis of CYP2C19 in Colombian mestizo nidividuals. BMC Clinical Pharmacology, 7. https://doi.org/10.1186/1472-6904-7-6Jurima-Romet, M., Goldstein, J. A., LeBelle, M., Aubin, R. A., Foster, B. C., Walop, W., & Rode, A. (1996). CYP2C19 genotyping and associated mephenytoin hydroxylation polymorphism in a Canadian Inuit population. Pharmacogenetics, 6(4), 329-339. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/8873219Klotz, U., Schwab, M., & Treiber, G. (2004). CYP2C19 polymorphism and proton pump inhibitors. Basic and Clinical Pharmacology and Toxicology. https://doi.org/10.1111/j.1600-0773.2004.pto950102.xLamba, J. K., Dhiman, R. K., & Kohli, K. K. (2000). CYP2C19 genetic mutations in North Indians. Clinical Pharmacology and Therapeutics, 68(3), 328-335. https://doi.org/10.1067/mcp.2000.109365Linden, R., Ziulkoski, A. L., Tonello, P., Wingert, M., & Souto, A. A. (2009). Relation between CYP2C19 phenotype and genotype in a group of Brazilian volunteers. Brazilian Journal of Pharmaceutical Sciences, 45(3), 461-467. https://doi.org/10.1590/S1984-82502009000300011Mansuy, D. (1994). Cytochromes P-450 and model systems: great diversity of catalyzed reactions. Pure and Applied Chemistry, 66(4), 737-744. https://doi.org/10.1351/pac199466040737Okey, A. B. (1990). Enzyme induction in the cytochrome P-450 system. Pharmacology and Therapeutics, 45(2), 241-298. https://doi.org/10.1016/0163-7258(90)90030-6Omura, T. (1999). Forty years of cytochrome P450. Biochemical and Biophysical Research Communications. https://doi.org/10.1006/bbrc.1999.1887Ozawa, S., Soyama, A., Saeki, M., Fukushima-Uesaka, H., Itoda, M., Koyano, S., … Sawada, J.-I. (2004). Ethnic differences in genetic polymorphisms of CYP2D6, CYP2C19, CYP3As and MDR1/ABCB1. Drug Metabolism and Pharmacokinetics, 19(2), 83-95. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/15499174Vangsted, A., Klausen, T. W., & Vogel, U. (2012). Genetic variations in multiple myeloma II: Association with effect of treatment. European Journal of Haematology. https://doi.org/10.1111/j.1600-0609.2011.01696.xMalgor, L., & Valsecia, M. (2000). Farmacología general: Farmacocinética. In Farmacología Médica (pp. 13-32).Patricia, A. L. C. F., & Gordillo, E. (2008). Los polimorfismos genéticos del Citocromo P450 y su relevancia en el metabolismo de xenobióticos Bioquímica del Breve historia del o rigen y evolución del CYP450. Analytical and Bioanalytical Chemistry.Viloria de La Hoz, J. (2003). Lorica, una colonia árabe a orillas del río Sinú. Cuadernos de Historia Económica Y Empresarial, (10), 1-91. Retrieved from http://www.banrep.gov.co/sites/default/files/publicaciones/archivos/chee_10.pdfLICENSElicense.txtlicense.txttext/plain; charset=utf-8368https://bonga.unisimon.edu.co/bitstreams/5e14ddac-0346-4504-bcfd-1e99daa2ed42/download3fdc7b41651299350522650338f5754dMD5220.500.12442/2122oai:bonga.unisimon.edu.co:20.500.12442/21222019-04-11 21:51:40.765metadata.onlyhttps://bonga.unisimon.edu.coDSpace UniSimonbibliotecas@biteca.comPGEgcmVsPSJsaWNlbnNlIiBocmVmPSJodHRwOi8vY3JlYXRpdmVjb21tb25zLm9yZy9saWNlbnNlcy9ieS1uYy80LjAvIj48aW1nIGFsdD0iTGljZW5jaWEgQ3JlYXRpdmUgQ29tbW9ucyIgc3R5bGU9ImJvcmRlci13aWR0aDowIiBzcmM9Imh0dHBzOi8vaS5jcmVhdGl2ZWNvbW1vbnMub3JnL2wvYnktbmMvNC4wLzg4eDMxLnBuZyIgLz48L2E+PGJyLz5Fc3RhIG9icmEgZXN0w6EgYmFqbyB1bmEgPGEgcmVsPSJsaWNlbnNlIiBocmVmPSJodHRwOi8vY3JlYXRpdmVjb21tb25zLm9yZy9saWNlbnNlcy9ieS1uYy80LjAvIj5MaWNlbmNpYSBDcmVhdGl2ZSBDb21tb25zIEF0cmlidWNpw7NuLU5vQ29tZXJjaWFsIDQuMCBJbnRlcm5hY2lvbmFsPC9hPi4=